--- title: "Americas Gold and Silver: Strong Q2 Beat, Operational Momentum and Deleveraging Support Buy Rating and Unchanged $12 Target" type: "News" locale: "en" url: "https://longbridge.com/en/news/293780596.md" description: "BMO Capital analyst Brian Quast reiterated a Buy rating on Americas Gold and Silver with an unchanged C$12 target, citing strong Q2 operational performance, exceeded production forecasts for silver, copper, lead, and antimony, and improved financial flexibility from deleveraging. H.C. Wainwright also maintained a Buy rating with a $9.75 target." datetime: "2026-07-24T15:05:32.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293780596.md) - [en](https://longbridge.com/en/news/293780596.md) - [zh-HK](https://longbridge.com/zh-HK/news/293780596.md) generator: "portal-rs" --- # Americas Gold and Silver: Strong Q2 Beat, Operational Momentum and Deleveraging Support Buy Rating and Unchanged $12 Target Analyst Brian Quast of BMO Capital reiterated a Buy rating on Americas Gold and Silver, retaining the price target of C$12.00. ### Claim 55% Off TipRanks - Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions - Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks Brian Quast has given his Buy rating due to a combination of factors, including stronger-than-expected operating performance and reaffirmed guidance. Americas Gold and Silver delivered second-quarter silver output that exceeded both his and the market’s forecasts, with both Cosalá and Galena performing above plan, while production of copper, lead, and antimony also surpassed expectations. Brian Quast’s rating is based on his view that the company can still meet its full-year production targets, supported by a planned ramp-up at Galena and recent infrastructure upgrades that should reduce operational disruptions. He also highlights that inventory builds and the removal of over US$85 million in future variable debt obligations improve the company’s financial flexibility, and with execution of its optimization strategy, he sees meaningful upside potential, justifying an unchanged $12 target price and a Buy recommendation. In another report released today, H.C. Wainwright also reiterated a Buy rating on the stock with a $9.75 price target. ### Related Stocks - [USAS.US](https://longbridge.com/en/quote/USAS.US.md) - [BMO.US](https://longbridge.com/en/quote/BMO.US.md) ## Related News & Research - [Americas Gold and Silver posts investor presentation on scaling high-grade silver and antimony output in Idaho Silver Valley](https://longbridge.com/en/news/296274815.md) - [Americas Gold and Silver Corporation (NYSEAMERICAN:USAS) Receives Consensus Rating of "Moderate Buy" from Analysts](https://longbridge.com/en/news/296226888.md) - [BioSyent GAAP EPS of C$0.25, revenue of C$19.87M](https://longbridge.com/en/news/296538491.md) - [Kenny Choi Sells 50,000 Shares of Belo Sun Mining (TSE:BSX) Stock](https://longbridge.com/en/news/296763306.md) - [First Trust Global Risk Managed Inc Index ETF declares CAD 0.05 dividend](https://longbridge.com/en/news/296824765.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**